PTP4A2 and neoplasm: Using a CNNM3 mutant (D426A) that has lost its capacity to interact with PRL-2 or a small molecule inhibitor of the complex formation between these two proteins, we showed that this interaction is important for breast cancer cell proliferation and tumor growth.